Rapid Detection & Response: State, territory, and local public health partners fight AR in health care, the community, and food.
Funding Amount: $919,128
CDC-funded HAI/AR Programs form a network of health departments that detect, prevent, respond to, and contain HAI/AR threats and promote appropriate use of antibiotics and antifungals. CDC’s AR Lab Network provides nationwide lab capacity to rapidly detect AR and inform local prevention and response activities to stop the spread of antimicrobial-resistant germs and protect people.
Food Safety projects protect communities by rapidly identifying antimicrobial-resistant foodborne bacteria to stop and solve outbreaks and improve prevention.
Funding Amount: $104,807
New Jersey uses whole genome sequencing to track local outbreaks of Listeria, Salmonella, Campylobacter, Shigella, and Escherichia coli, identifies AR genes, and shares surveillance data with PulseNet. When outbreaks are detected, local CDC-supported epidemiologists respond to stop their spread.
Drug-resistant Gonorrhea Detect & Respond Program works with state and local epidemiology and laboratory partners to test for and quickly respond to resistant gonorrhea to stop its spread in high-risk communities. Only one recommended treatment option remains for gonorrhea and resistance to other antibiotics continues to grow.
Funding Amount: $15,000
The Gonococcal Isolate Surveillance Project (GISP) informs national treatment guidelines for gonorrhea by monitoring how well antibiotics work on laboratory samples collected from sentinel STD clinics, which often are the first to detect the threat. Select STD clinics also enhance surveillance by collecting additional gonococcal isolates from women and from extragenital sites. This work is jointly supported by CDC STI and AR funds.
Global Tuberculosis Institute at Rutgers, The State University of New Jersey: Innovative Prevention & Tracking
Funding Amount: $3,750
CDC's Tuberculosis (TB) Centers of Excellence for Training, Education, and Medical Consultation (COEs) increase knowledge, skills, and abilities for TB prevention and control through communication, education, and training activities. The COEs also improve sustainable evidence-based TB clinical practices and patient care through the provision of expert medical consultation.
AR | antimicrobial resistance |
COVID-19 | coronavirus disease 2019 |
HAI | healthcare-associated infection |
IPC | infection prevention and control |
NHSN | National Healthcare Safety Network |
STI | sexually transmitted infection |
STD | sexually transmitted disease |